Sureda A, Pavlovsky A, Haidar D, Kristo F, et al. Real-world outcomes of brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in relapsed/refractory Hodgkin lymphoma: A systematic review and meta-analysis. Bone Marrow Transplant 2025 Apr 8. doi: 10.1038/s41409-025-02557.
PMID: 40200006